Aplikace z oblasti Farmaceutická analýza od Waters - strana 2
Otevřít dokument Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LC/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
HPLC
Instrumentace
HPLC
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Rapid LC-UV/MS Workflow for Routine Oligonucleotide Impurity Monitoring Using the SQ Detector 2 Mass Detector and Empower™ Chromatography Data System (CDS)
Rapid LC-UV/MS Workflow for Routine Oligonucleotide Impurity Monitoring Using the SQ Detector 2 Mass Detector and Empower™ Chromatography Data System (CDS)
LC/MS, Software, LC/SQ
Instrumentace
LC/MS, Software, LC/SQ
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument The Quantification of Glucagon-like Peptide Receptor Agonists (GLP-1 RAs) in Plasma Extracts Using Capillary UHPLC-MS/MS
The Quantification of Glucagon-like Peptide Receptor Agonists (GLP-1 RAs) in Plasma Extracts Using Capillary UHPLC-MS/MS
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Waters
Zaměření
Farmaceutická analýza, Klinická analýza
Otevřít dokument Column Robustness Across 2000 Injections of a Small Molecule Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Orforglipron Formulation
Column Robustness Across 2000 Injections of a Small Molecule Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Orforglipron Formulation
Spotřební materiál, LC kolony, HPLC
Instrumentace
Spotřební materiál, LC kolony, HPLC
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument From Extractables Screening to Targeted Leachables Quantitation Using DDA and Tof- MRM on the Xevo™ MRT Mass Spectrometer
From Extractables Screening to Targeted Leachables Quantitation Using DDA and Tof- MRM on the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
